Mendel Money Management Has $219,000 Holdings in The Clorox Company (NYSE:CLX)

Mendel Money Management reduced its stake in shares of The Clorox Company (NYSE:CLX) by 6.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,346 shares of the company’s stock after selling 90 shares during the quarter. Mendel Money Management’s holdings in Clorox were worth $219,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Thrivent Financial for Lutherans raised its position in shares of Clorox by 2.7% in the third quarter. Thrivent Financial for Lutherans now owns 9,091 shares of the company’s stock valued at $1,481,000 after purchasing an additional 236 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after acquiring an additional 13,038 shares during the last quarter. Nwam LLC bought a new stake in Clorox during the third quarter valued at about $289,000. Cerity Partners LLC grew its position in shares of Clorox by 13.5% in the third quarter. Cerity Partners LLC now owns 52,454 shares of the company’s stock valued at $8,545,000 after purchasing an additional 6,232 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its stake in shares of Clorox by 2.9% in the third quarter. Daiwa Securities Group Inc. now owns 15,240 shares of the company’s stock worth $2,483,000 after purchasing an additional 426 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of CLX stock opened at $141.80 on Wednesday. The firm’s 50 day moving average price is $152.23 and its two-hundred day moving average price is $159.43. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market cap of $17.47 billion, a PE ratio of 38.74, a PEG ratio of 2.62 and a beta of 0.45. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the firm earned $2.16 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.44%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is presently 133.33%.

Wall Street Analyst Weigh In

CLX has been the subject of several recent analyst reports. DA Davidson decreased their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Evercore ISI raised their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays upped their target price on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Wells Fargo & Company increased their target price on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $159.62.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.